Experts have analysed the model ranges, global performance and expanding footprint of all the major Chinese players currently ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...
Last year McLaren Automotive revealed the next instalment in its '1' hypercar series, and it will be the most powerful ...
Carlos Tavares, the first CEO of Stellantis, believes the French-Italian-American firm may be too unwieldily to manage and ...